We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

108 hedge funds and large institutions have $533M invested in Albireo Pharma Inc in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 9

96% more capital invested

Capital invested by funds: $272M → $533M (+$261M)

42% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 26

32% more funds holding

Funds holding: 82 → 108 (+26)

86% less call options, than puts

Call options by funds: $7.05M | Put options by funds: $51.1M

Holders
108
Holders Change
+26
Holders Change %
+31.71%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
35
Increased
37
Reduced
26
Closed
9
Calls
$7.05M
Puts
$51.1M
Net Calls
-$44.1M
Net Calls Change
-$47.6M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$20.4M
2
Marshall Wace
Marshall Wace
United Kingdom
+$17.7M
3
CAC
Cowen and Company
New York
+$17.5M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$14.6M
5
SCM
Sio Capital Management
New York
+$13.9M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.64M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$4.61M
3
PM
Prosight Management
Texas
-$2.22M
4
SCM
Suvretta Capital Management
New York
-$2.14M
5
EP
Eversept Partners
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$3.78M +$2.42M +83,170 +277%
Deutsche Bank
27
Deutsche Bank
Germany
$3.44M -$407K -13,987 -12%
HA
28
Heartland Advisors
Wisconsin
$3.34M -$1.46M -50,000 -33%
SB
29
Samsara BioCapital
California
$3.34M +$2.91M +100,000 New
RHJA
30
Rice Hall James & Associates
California
$2.92M +$2.54M +87,358 New
N
31
Nuveen
North Carolina
$2.48M +$318K +10,927 +17%
PCM
32
Pinz Capital Management
New York
$2.4M +$2.1M +72,000 New
BC
33
Birchview Capital
Vermont
$1.94M +$291K +10,000 +21%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.77M -$33.7K -1,158 -2%
ECM
35
Endurant Capital Management
California
$1.74M +$1.52M +52,131 New
Alyeska Investment Group
36
Alyeska Investment Group
Illinois
$1.67M +$1.46M +50,000 New
William Blair & Company
37
William Blair & Company
Illinois
$1.6M +$320K +10,970 +30%
PPA
38
Parametric Portfolio Associates
Washington
$1.48M +$397K +13,626 +44%
EGM
39
Engineers Gate Manager
New York
$1.48M +$1.29M +44,253 New
Goldman Sachs
40
Goldman Sachs
New York
$1.47M +$740K +25,407 +135%
Verition Fund Management
41
Verition Fund Management
Connecticut
$1.43M +$1.25M +42,908 New
Victory Capital Management
42
Victory Capital Management
Texas
$1.41M -$129K -4,420 -9%
EGI
43
EAM Global Investors
California
$1.39M +$1.21M +41,624 New
Two Sigma Advisers
44
Two Sigma Advisers
New York
$1.29M +$498K +17,100 +79%
Group One Trading
45
Group One Trading
Illinois
$1.27M +$1.11M +38,148 New
MWNA
46
Marshall Wace North America
New York
$1.25M +$1.09M +37,393 New
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$1.13M +$1.04M +35,600 New
Charles Schwab
48
Charles Schwab
California
$1.1M -$39.2K -1,347 -4%
Wells Fargo
49
Wells Fargo
California
$1.04M -$38.1K -1,309 -4%
EI
50
EAM Investors
California
$973K +$849K +29,151 New
1
2
3 4 5

ALBO Hedge Fund Activity: Q3 2020 in Review

108 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2020, worth a combined $533M — up 96% from $272M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ALBO positions and 9 closed out — a net gain of 26 holders — while 37 added to existing stakes and 26 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $20.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $4.64M sold.

  • 108 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2020, up from 82 in Q2 2020.
  • Funds reported $533M of Albireo Pharma Inc stock for Q3 2020, up 96% quarter-over-quarter.
  • 35 funds opened new Albireo Pharma Inc positions in Q3 2020 and 9 closed out, a net change of +26 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2020 was Cormorant Asset Management, an estimated $20.4M added.
  • The largest Albireo Pharma Inc seller in Q3 2020 was Point72 Asset Management, an estimated $4.64M sold.

Based on aggregated 13F filings for Q3 2020.